Syncom Formulations (India) Ltd Share Price
(SYNCOMF)
₹17.45▲2.83%
as on 02:27PM, 20 Feb 2025
Syncom Formulations (India) Ltd Performance
Day's Low
Day's High
₹16.85Day's Price Range₹17.5452 Week's Low
52 Week's High
₹10.9552-Week Price Range₹27.9
| Returns % | |
| 1 Month Return | -10.31 % |
| 3 Month Return | -14.16 % |
| 1 Year Return | + 7.07 % |
| Market Stats | |
| Previous Close | ₹16.97 |
| Open | ₹17.45 |
| Volume | 19.89L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,595.18Cr |
Syncom Formulations (India) Ltd Key Statistics
P/E Ratio
33.27
PEG Ratio
195.73
Market Cap
₹1,595.18 Cr
P/B Ratio
3.67
EPS
0.27
Dividend Yield
0Sector
Pharmaceuticals
ROE
8.71
Syncom Formulations (India) Ltd Mutual Fund Holdings
Key events for Syncom Formulations (India) Ltd
Syncom Formula Reports Strong Growth in December 2024 - 14 Feb, 2025
Syncom Formula's standalone net sales for December 2024 reached Rs 127.03 crore, up 100.54% YoY. Net profit rose 99.22% to Rs 12.79 crore, with EBITDA increasing by 65.29%. EPS improved to Rs 0.14. The stock closed at Rs 18.04 on February 12, 2025, reflecting positive returns over the past 6 and 12 months.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 7 quarters, 4.4 Cr → 13.0 Cr (in ₹), with an average increase of 15.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, SYNCOMF stock has moved up by 4.2%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.10% to 0.13% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 61.71 Cr → 131.57 Cr (in ₹), with an average increase of 11.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 52.8%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 75.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 49.33% to 49.30% in Dec 2024 quarter
Syncom Formulations (India) Ltd Financials
Index Inclusions
Syncom Formulations (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.13% | 28.33 | |
| Mutual Funds | 0% | 28.57 | |
| Retail Investors | 49.3% | ||
| Others | 0% | 0.00 |
Syncom Formulations (India) Ltd Key Indicators
Syncom Formulations (India) Ltd Valuation
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (33.27x)
February 19, 2025
Industry (51.87x)
February 19, 2025
Highest (81.74x)
January 18, 2022
Syncom Formulations (India) Ltd Earnings and Dividends
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit jumped 85.71% since last year same period to ₹13Cr in the Q3 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 17.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.18%.
Read More about Dividends
Syncom Formulations (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Syncom Formulations (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
Syncom Formulations (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,595.18 Cr | 464.86% | 0.61 | ₹25 Cr | ₹263 Cr | |
| NA | ₹102.38 Cr | 43.14% | 0.73 | NA | NA | |
| HOLD | ₹14,561.63 Cr | 4.54% | 0.54 | ₹1,388 Cr | ₹3,998 Cr | |
| BUY | ₹7,790.22 Cr | -7.57% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
| NA | ₹368.31 Cr | 191.73% | 0.54 | ₹23 Cr | ₹164 Cr |
About Syncom Formulations (India) Ltd
Share Price: ₹17.45 per share as on 20 Feb, 2025 02:27 PM
Market Capitalisation: ₹1,595.18Cr as of today
Revenue: ₹127.53Cr as on December 2024 (Q4 24)
Net Profit: ₹13.00Cr as on December 2024 (Q4 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Syncom Formulations (India) Ltd
What is Syncom Formulations (India) Ltd price today?
Syncom Formulations (India) Ltd share price today stands at ₹17.45, Open: ₹17.45, Previous Close: ₹16.97, High: ₹17.54, Low: ₹16.85, 52 Week High: ₹27.9, 52 Week Low: ₹10.95.
How to Buy Syncom Formulations (India) Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Syncom Formulations (India) Ltd shares
Is Syncom Formulations (India) Ltd listed on NSE?
Syncom Formulations (India) Ltd is listed on NSE
Is Syncom Formulations (India) Ltd listed on BSE?
Syncom Formulations (India) Ltd is listed on BSE
What are today's High and Low prices of Syncom Formulations (India) Ltd?
- Today's highest price of Syncom Formulations (India) Ltd is ₹17.54.
- Today's lowest price of Syncom Formulations (India) Ltd is ₹16.85.
What are today's traded volumes of Syncom Formulations (India) Ltd?
Today's traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 19.89L.
What is today's market capitalisation of Syncom Formulations (India) Ltd?
Today's market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1595.18Cr.
What is the 52 Week High and Low Range of Syncom Formulations (India) Ltd?
How much percentage Syncom Formulations (India) Ltd is down from its 52 Week High?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.45. It is down -37.46% from its 52 Week High price of ₹27.9
How much percentage Syncom Formulations (India) Ltd is up from its 52 Week low?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.45. It is up 59.36% from its 52 Week Low price of ₹10.95
What are the historical returns of Syncom Formulations (India) Ltd?
What is the PE ratio of Syncom Formulations (India) Ltd today?
PE Ratio of Syncom Formulations (India) Ltd is 33.27
PE ratio = Syncom Formulations (India) Ltd Market price per share / Syncom Formulations (India) Ltd Earnings per share